NCT02248142 Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS) Status COMPLETED Phase N/A
NCT02248129 Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide Status COMPLETED Phase N/A
NCT02248116 Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type Status TERMINATED Phase PHASE2/PHASE3
NCT02247375 Pharmacokinetics, Safety and Efficacy of BIIL 284 BS in Patients With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE1
NCT02245555 Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia Status COMPLETED Phase N/A
NCT02245542 The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) Status COMPLETED Phase N/A
NCT02245529 Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia Status COMPLETED Phase N/A
NCT02245503 Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH) Status COMPLETED Phase N/A
NCT02245490 Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms Status COMPLETED Phase PHASE4
NCT02245464 Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension Status COMPLETED Phase N/A
NCT02245451 Study of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Methadone Administered in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02245438 Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers Status TERMINATED Phase PHASE1
NCT02245269 Pharmacokinetics of Atorvastatin With Tipranavir/Ritonavir and the Effect of Antacid on the Pharmacokinetics of Single-Dose Tipranavir/Ritonavir in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02244346 Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH) Status COMPLETED Phase N/A
NCT02244333 Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS) Status COMPLETED Phase N/A
NCT02244320 Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin) Status COMPLETED Phase N/A
NCT02244307 Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade Status COMPLETED Phase N/A
NCT02244294 FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH) Status COMPLETED Phase PHASE2
NCT02244281 Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms Status COMPLETED Phase PHASE2
NCT02244268 Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia Status COMPLETED Phase N/A